Medical marijuana utilization in gynecologic cancer patients
Abstract Medical marijuana was used by gynecologic cancer patients a median of 5.2 (range 0.6–25.4) months. The most common indications for medical marijuana use were pain, nausea/vomiting, anorexia and insomnia. Medical marijuana relieved at least one cancer- or treatment-related symptom in 71% of patients. Only 15% of patients discontinued medical marijuana secondary to side effects. Article type: Case Report Keywords: Medical marijuana, Gynecologic cancer, Cannabis, Management of treatment-related toxicity, Symptom control Authors: Julia Fehniger, Allison L. Brodsky, Arum Kim, Bhavana
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
